Pfizer CFO Says Still Expects 2023 Rev Of $58B–$61B Vs $54.63B Est; Says Expects 2023 EPS $1.45-$1.65 Vs $1.45 Est.
Portfolio Pulse from Benzinga Newsdesk
Pfizer's CFO reaffirmed the company's revenue expectation for 2023 to be between $58B and $61B and projected EPS to range from $1.45 to $1.65 during a conference call.
December 13, 2023 | 1:48 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Pfizer's CFO has confirmed the 2023 revenue forecast to be between $58B and $61B and expects EPS to be in the range of $1.45 to $1.65.
The reaffirmation of revenue and EPS guidance by Pfizer's CFO suggests a stable financial outlook, which is likely to maintain investor confidence. However, since this is a reiteration of previous guidance rather than new information, the short-term impact on the stock price is likely to be neutral.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100